Mahlangu J, Iorio A, Kenet G. Emicizumab state-of-the-art update. Haemophilia. 2022;28 Suppl 4(Suppl 4):103-10. https://pubmed.ncbi.nlm.nih.gov/35521723/
Emicizumab state-of-the-art update.
By Peter Matlawa|2023-03-29T09:59:14+02:00March 29, 2023|2022: April to June|Comments Off on Emicizumab state-of-the-art update.
Share This Story, Choose Your Platform!
About the Author: Peter Matlawa
Related Posts
Antimicrobial susceptibility and genomic profiling of Salmonella enterica from bloodstream infections at a tertiary referral hospital in Lusaka, Zambia, 2018-2019.